临床应用 FAPI 成像是否正在改变实体胃肠道（或消化系统）肿瘤的 PET/CT 成像模式？
Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors With the Clinical Application of FAPI Imaging?
机构信息
From the Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Logroño, La Rioja.
Department of Pathology, University Hospital "Marqués de Valdecilla," Santander, Spain.
出版信息
Clin Nucl Med. 2023 Apr 1;48(4):318-319. doi: 10.1097/RLU.0000000000004602. Epub 2023 Feb 8.
Studies with [ 68 Ga]Ga-labeled or [ 18 F]F-labeled fibroblast activation protein inhibitor compounds have demonstrated favorable characteristics for PET/CT imaging, making them especially interesting for digestive tumors. In this review, the recent evidence in this field and its potential clinical applications are discussed.
研究表明，[68Ga]Ga 标记或[18F]F 标记的成纤维细胞激活蛋白抑制剂化合物具有适合 PET/CT 成像的特点，因此特别适用于消化道肿瘤。本文讨论了该领域的最新证据及其潜在的临床应用。
Zotero 插件